Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Economic evaluation of Cardio inCode®, a clinical-genetic function for coronary heart disease risk assessment.

Applied health economics and health policy - 1 Oct 2013

Ramírez de Arellano A, Coca A, de la Figuera M, Rubio-Terrés C, Rubio-Rodríguez D, Gracia A, Boldeanu A, Puig-Gilberte J, Salas E

Abstract excerpt

BACKGROUND: A clinical–genetic function (Cardio inCode®) was generated using genetic variants associated with coronary heart disease (CHD), but not with classical CHD risk factors, to achieve a more precise estimation of the CHD risk of individuals by incorporating genetics into risk equations [Framingham and REGICOR (Registre Gironí del Cor)]. OBJECTIVE: The objective of this study was to conduct an economic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age Factors
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Coronary Disease

Share to Cost-Benefit Analysis

Share to Markov Chains

Share to Probability

Share to Risk Assessment

Source

Open in PubMed Open full text

Identifiers

PMID: 24078223
DOI: 10.1007/s40258-013-0053-x
PMCID: PMC3825137

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

Economic evaluation of Cardio inCode®, a clinical-genetic function for coronary heart disease risk assessment.PMID 24078223Read ↗

Cost-effectiveness of implementing a genotype-guided de-escalation strategy in patients with acute coronary syndrome.Semantic proximity Read ↗

Economic analysis of thrombo inCode, a clinical-genetic function for assessing the risk of venous thromboembolism.Semantic proximity Read ↗

Cost Effectiveness of a CYP2C19 Genotype-Guided Strategy in Patients with Acute Myocardial Infarction: Results from the POPular Genetics Trial.Semantic proximity Read ↗

Synthesized Economic Evidence on the Cost-effectiveness of Screening Familial Hypercholesterolemia: A meta-analytic review and Aggregate Distributional Cost-Effectiveness AnalysisSemantic proximity Read ↗

Economic evaluation of pharmacogenomic-guided warfarin treatment for elderly Croatian atrial fibrillation patients with ischemic stroke.Semantic proximity Read ↗

Health economic analysis of polygenic risk score use in primary prevention of coronary artery disease – A system dynamics modelSemantic proximity Read ↗

Ex Ante Economic Evaluation of Arg389 Genetically Targeted Treatment with Bucindolol versus Empirical Treatment with Carvedilol in NYHA III/IV Heart Failure.Semantic proximity Read ↗

Target trial emulation for a two-arm, parallel, stratified pragmatic RCT of CABG versus PCI in people with high-risk characteristics requiring myocardial revascularisation (High-Risk REVASC)Semantic proximity Read ↗

The Conceptualization of Cardiometabolic Disease Policy Model in the UKSemantic proximity Read ↗

Determining Cost-Saving Risk Thresholds for Statin UseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.